Disclosure Of Revenue From Contracts With Customers [Text Block]

OSE Immunotherapeutics - Filing #5980970

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of revenue from contracts with customers [text block]
8.1.
Revenue from contracts with customers
69 877 EUR
2 227 EUR
Disclosure of disaggregation of revenue from contracts with customers [text block]
Disclosure of disaggregation of revenue from contracts with customers [abstract]
Disclosure of disaggregation of revenue from contracts with customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.